Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks to buy, according to Wall Street analysts. On December 8, the company confirmed the dosing of the first patients in its Phase 3 OPUS trial ...

A new scientific review has uncovered how complex microbial communities, including those in the human gut and the natural environment, act as powerful ...

Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult ...

Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...

Merck , known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its publicly funded ...

Learn why child mortality is rising for the first time in our lives - and how smarter investments, innovation, and science ...

Pneumonia cases surge in winter as cold, pollution, and viruses weaken immunity. Dr. Agrawal urges early diagnosis, awareness ...

Gut transit time influences digestion, nutrient absorption, fermentation, and microbiome balance, explaining why similar diets can lead to different gut health outcomes.

A study reveals that the liver acts as a bidirectional hub, exchanging gut-microbiome-derived metabolic products with the ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

If you experience constipation, irregular bowel habits, bloating, or other gut discomfort, it may not only be what you eat ...